Oura to acquire AI-based primary care startup Counsel Health for $625 million
startup
| Source: TechCrunch | Original article
Oura announced a $625 million acquisition of AI‑native primary‑care startup Counsel Health, after indefinitely postponing its up‑to‑$2.2 billion IPO amid market uncertainty.
Oura ring maker Oura has agreed to buy AI‑native primary‑care startup Counsel Health for $625 million. The acquisition, announced this week, marks a decisive pivot from the wearable‑focused business that has defined the Finnish‑based company since its 2015 launch. By adding Counsel Health’s artificial‑intelligence‑driven care platform, Oura aims to broaden its health‑tech portfolio beyond sleep and activity tracking into full‑service primary care.
The deal arrives just weeks after Oura shelved a planned initial public offering that could have raised up to $2.2 billion, citing “uncertainty in the IPO market.” The postponement left the company with a sizable cash reserve and a need to demonstrate a clear growth trajectory. Integrating an AI‑powered clinical service offers a path to recurring revenue and deeper user engagement, potentially making the business more attractive to investors when market conditions improve.
For the Nordic AI ecosystem, the transaction underscores a growing trend of hardware firms leveraging home‑grown AI capabilities to expand into digital health. Counsel Health’s technology, built around machine‑learning models that triage symptoms and personalize treatment plans, could be combined with Oura’s biometric data to create a more holistic health‑management loop. If successful, the move may inspire similar cross‑industry collaborations across Europe, where data privacy regulations and strong health‑tech talent pools provide a fertile ground for AI‑driven care solutions.
What to watch next: regulatory clearance for the merger, the speed and depth of integration between Oura’s sensor data and Counsel Health’s AI platform, and any signals from investors about a renewed IPO timetable. Market analysts will also be keen to see whether the combined entity can achieve cost efficiencies and generate the recurring revenue streams needed to justify the $625 million price tag.
Sources
Back to AIPULSEN